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Background Data on non-communicable disease (NCD) burden are often limited
in developing countries in Africa but crucial for planning and im-
plementation of prevention and control strategies. We assessed the
prevalence of related cardiovascular disease risk factors (hypergly-
caemia, high blood pressure and obesity) in a longstanding popu-
lation cohort in rural Uganda.
Methods Trained field staff conducted a cross-sectional population-based
survey of cardiovascular disease risk indicators using a question-
naire and simple measurements of body mass index (BMI), waist
and hip circumference, waist/hip ratio (WHR), blood pressure and
random plasma glucose. All members of the population cohort aged
513 years were eligible to participate in the survey.
Results Of the 4801 males and 5372 females who were eligible, 2719
(56.6%) males and 3959 (73.7%) females participated in the
survey. Male and female participants had a mean standard
deviation (SD) age of 31.8 (18.4) years and 33.7 (17.6) years,
respectively. The observed prevalences of probable diabetes (glucose
411.0mmol/l) and probable hyperglycaemia (7.0–11.0mmol/l) were
0.4 and 2.9%, respectively. Less than 1% of males and 4% of females
were obese (BMI 530kg/m
2), with 3.6% of males and 14.5% of
females being overweight (BMI 25.0–29.9kg/m
2). However, in
women, the prevalence of abdominal obesity was high (71.3% as
measured by WHR and 31.2% as measured by waist circumference).
The proportions of male and female current regular smokers were
low (13.7 and 0.9%, respectively). The commonest cardiovascular
disease risk factor was high blood pressure, with an observed
prevalence of 22.5% in both sexes.
Conclusions Population-based data on the burden of related cardiovascular
disease risk factors can aid in the planning and implementation
of an effective response to the double burden of communicable
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160diseases and NCDs in this rural population of a low-income country
undergoing epidemiological transition.
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Introduction
Diabetes is an important cause of morbidity and
mortality worldwide,
1 and with hypertension and
obesity it is an important risk factor for cardiovascular
disease,
2 a leading global cause of death.
3 Type 2 dia-
betes, hypertension and obesity share several charac-
teristics: (i) their common risk factors (unhealthy
diets, physical inactivity and harmful alcohol use)
and other exacerbating factors (e.g. tobacco use) are
potentially amenable to behavioural modification;
4
(ii) they can be detected using simple tests and
managed in primary-care settings in low-income
countries;
5 (iii) the benefits of prevention and care
extend beyond cardiovascular disease to related con-
ditions of public health importance;
6 (iv) they are the
focus of efforts to ensure greater prioritization of
non-communicable diseases (NCDs) on the global re-
search agenda,
7 the research agenda of development
agencies
8 and in the health and development policies
of low-income countries.
9
With globalization, chronic NCDs are becoming
more common in developing countries,
10 with the
greatest regional increase in NCD deaths over the
next decade predicted in Africa.
9 Emerging country-
level evidence, e.g. from South Africa,
11 suggests that
chronic NCDs are contributing to epidemiological
transition (concomitant high burdens of both com-
municable diseases and NCDs) in many low-income
countries.
12 Recent estimates indicate the global
burden of chronic NCDs: 285 million people with dia-
betes in 2010,
1 972 million with hypertension in
2000
13 and 400 million adults with obesity in 2005.
3
About 65–70% of those with diabetes or hypertension
live in the developing world.
1,13
NCDs such as diabetes are poorly understood and
under-prioritized in developing countries.
14 Informa-
tion on diabetes prevalence is often limited in
low-income countries, particularly in sub-Saharan
Africa and in rural populations.
15 For example, the
2010 International Diabetes Federation Atlas found
that only four African countries (Uganda not
included) possessed data, mostly 410 years old.
1
Since data have to be extrapolated from distant and
probably dissimilar countries and populations, further
epidemiological investigation in the region is urgently
needed.
15 Good-quality data on disease burden are
crucial to aid planning and implementation of preven-
tion and control strategies for diabetes and other
chronic NCDs.
16 Detailed epidemiological studies
help in understanding NCD pathogenesis and in ra-
tional clinical management. A large population-based
cohort in rural southwest Uganda, initially established
in 1989 for human immunodeficiency virus (HIV)
surveillance,
17,18 provided the opportunity to assess
community prevalence in adults of hyperglycaemia,
high blood pressure and obesity, selected for survey
on account of their shared characteristics and their
importance as cardiovascular disease risk factors.
Methods
Setting
Uganda has been recovering since 1986 from previous
civil, political and economic turmoil. The estimated
30 million population are mostly engaged in subsist-
ence agriculture. Annual Gross National Income is
$300 per capita and mean life expectancy at birth is
50years.
19 It is one of the countries in Africa where
the HIV epidemic was first reported and that was
initially most badly affected by HIV.
The study cohort comprises approximately 20000
residents of 25 neighbouring villages in south-western
Uganda, not far from Lake Victoria. The vast majority
of dwellings are distributed throughout the country-
side rather than clustered in villages, which mainly
represent administrative areas demarcated on maps
rather than population centres. The study population
are mostly subsistence farmers, whose staple diet con-
sists of matooke (cooking bananas) with groundnuts.
There are no tarmac roads and access may be difficult
during the rains. People live in semi-permanent struc-
tures built from locally available materials. The com-
munity is stable and homogeneous, with most people
from the Baganda tribe, and 15% of Rwandese origin,
who are well assimilated. Religious affiliation is
mostly Christian, with a significant Muslim minority
(28%). Levels of literacy are low and the main
income-earning activities are growing bananas,
coffee and beans, and trading fish.
20
Annual general population cohort survey
Full details of the cohort and annual HIV serosurvey
have been published elsewhere.
17,18 In brief, an
annual household survey has been conducted since
1989, with all study-village residents eligible for in-
clusion. Average annual serosurvey participation is
 60–65%, although a much higher percentage has
ever participated. Community-sensitization activities
precede each survey round, including local council
briefings and village meetings. All households are vis-
ited by, in turn, the mapping, census and survey
teams. Consenting residents are interviewed at home
in the local language by trained survey staff and pro-
vide a blood sample for HIV testing.
CROSS-SECTIONAL POPULATION-BASED SURVEY IN RURAL UGANDA 161Measurement of indicators of cardiovascular
disease risk
As part of the 20th annual HIV serosurvey (December
2008–November 2009), field staff assessed consenting
adults (defined for the HIV serosurvey as aged
513 years) for indicators of cardiovascular disease
risk using a questionnaire and simple measurements.
Study participants with an abnormal finding were
advised to attend their nearest local health facility
or the study clinic for further management. Question-
naire information included socio-demographic factors
(including education level) and economic status.
Socio-economic status (SES) was measured using an
asset index, created by combining data on 22 house-
hold possessions using principal component analysis.
Participants were asked if they were currently, or ever
used to be, a regular cigarette smoker (including both
manufactured and local cigarettes), if they had dia-
betes or hypertension and if they were already attend-
ing a clinic for either condition.
Anthropometric measurements were taken on
standing participants wearing light clothes and with-
out shoes. Weight was measured to the nearest 0.1kg,
using a spring balance, and height to the nearest
0.5cm, using a stadiometer. Waist and hip circumfer-
ences were measured to the nearest 0.1cm using
standard techniques.
21 A single measurement of
blood pressure was taken on the left arm of seated
subjects after resting for 15min, using a machine
with an inflatable 15-cm cuff and automatic digital
read-out to within 1mmHg (WelchAllyn OSZ 5 easy)
(note: WelchAllyn confirm that the ‘OSZ 5 easy’ is the
same device as Microlife BP 3BTO-A, originally man-
ufactured by Microlife).
22 Body mass index (BMI)
was calculated as an indicator of obesity (BMI
530kg/m
2) and overweight (BMI¼25.0–29.9kg/m
2).
23
Waist/hip ratio (WHR) and waist circumference (WC)
were used as indicators of abdominal obesity (defined
respectively as WHR 40.95 for men and 40.80 for
women
24 and WC 494cm for men and 480cm
for women).
25 High blood pressure (possible hyper-
tension) was defined as systolic blood pressure
5140mmHg or diastolic blood pressure 590mmHg.
26
During venepuncture for HIV serotesting, a 4-ml
blood sample was taken from participants into a
tube containing oxalate and sodium fluoride for a
random plasma glucose measurement, and trans-
ported to the laboratory at the nearby rural field sta-
tion for centrifugation and storage of 1-ml plasma
aliquots at 2–88C. Samples were transported the fol-
lowing day using a cool box with ice packs to
Entebbe, where plasma glucose was measured at the
research unit main laboratory using the enzymatic
reference method with hexokinase (Roche COBAS
Integra 400 analyser with Glucose HK Gen.3 reagent).
Daily calibration of the glucose assay was performed
with normal and elevated control solutions provided
by the manufacturer. The laboratory also participates
in the external quality assurance programme of
National Health Laboratory Services of South Africa,
which involves monthly checks and feedback on
glucose and other analytes. The results of random
plasma glucose tests were interpreted as effect-
ively post-prandial: <7mmol/l was normal, 7.0–
11.0mmol/l indicated probable hyperglycaemia and
411.0mmol/l indicated probable diabetes.
27 For par-
ticipants who declined HIV testing, HIV serostatus
was obtained from the last available serosurvey result.
Statistics
Data were double-entered and verified in Access.
Stata 10 (Stata Corporation, College Station, USA)
was used for analyses. Characteristics of persons
with plasma glucose 57mmol/l (i.e. probable hyper-
glycaemia or diabetes) and those with normal plasma
glucose were compared using chi-squared tests for
categorical variables, and t-tests for continuous data.
As a sensitivity analysis, we compared our estimate
of diabetes prevalence based on random plasma glu-
cose results with the estimate obtained when partici-
pants who reported having diabetes, but had normal
glucose results, were included as probable diabetes. In
addition, the overall age-standardized prevalence of
probable diabetes and possible diabetes was calcu-
lated by combining observed prevalence with
age-stratified population estimates from the study
population in the 2008 census round.
Lastly, we investigated factors associated with the
observed prevalence of probable hyperglycaemia/dia-
betes (i.e. plasma glucose 57mmol/l) using random
effects logistic regression to account for correlation
within households. Because the prevalence of
random plasma glucose 411mmol/l was so low, we
combined the groups with probable diabetes and
probable hyperglycaemia as our outcome of interest.
Exposures of interest included socio-demographic
variables and clinical factors. Our hypothesis was
that known cardiovascular disease risk factors, such
as obesity and abdominal fat mass, would be asso-
ciated with the prevalence of elevated plasma glucose
in our study population. Analyses were stratified by
sex because it was thought that some associations
might differ between males and females. All factors
whose univariate association with the outcome
reached significance at P<0.20 were considered for
inclusion in a multivariable analysis. Ordered categor-
ical variables for which the likelihood ratio test for
departure from linearity was not significant at
P<0.05 were fit as linear terms. High blood pressure
was considered to be a possible consequence of, rather
than a risk factor for, plasma glucose 57mmol/l, so
was not included in the final multivariable model.
Instead, the association between high blood pressure
and the prevalence of glucose 57mmol/l was assessed
after adjusting for independent predictors of elevated
glucose. The final multivariable model was reached by
excluding factors one at a time until all remaining
factors were significant at the P<0.10 level.
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Results
Characteristics of cohort participants
At census, there were 4801 males and 5372 females
aged 513 years resident in the study area and eligible
as survey participants. Of those, 2719 (56.6%) males
and 3959 (73.7%) females responded to the survey
questionnaire (Figure 1).
Participation was lower in younger age groups, for
both sexes, and among women 560 years. The mean
standard deviation (SD) age of responders was
31.8 (18.4) years for males and 33.7 (17.6) years for
females (Table 1). There was strong evidence of
higher SES among non-responders, with 25% of
non-responders in the highest SES quintile compared
with 22.6% of responders (P¼0.001). There was no
evidence of a difference in HIV serostatus between
responders and non-responders, with 6.0 vs 6.2%
being HIV seropositive, respectively (P¼0.78).
Prevalence of hyperglycaemia, high blood
pressure and obesity
The observed prevalence of probable diabetes was
0.4% in both males and females, and of probable
hyperglycaemia was 3% in males and 2.8% in females
(Table 1). Age-standardized prevalences of probable
diabetes and probable hyperglycaemia were 0.4%
[95% confidence interval (CI) 0.3–0.5] and 2.8%
(95% CI 2.5–3.1), respectively. The observed preva-
lence of high blood pressure was 22.5% in males
and 22.6% in females. Less than 1% of males and
4% of females were obese (BMI 530kg/m
2), and
3.6% of males and 14.5% of females were
overweight (BMI 25–29.9kg/m
2). The prevalence of
under-nutrition (BMI<18.5kg/m
2) was 29.8%
in males and 16.5% in females. Using standard
cut-offs, the proportions of participants with
abdominal obesity among males and females were
3.8 and 71.3% (WHR) and 1.0 and 31.2% (WC),
respectively.
Most people with probable diabetes or hypergly-
caemia were not aware of it: 74% of persons with
plasma glucose 411mmol/l and 98% of those with
plasma glucose 57mmol/l did not report having dia-
betes. There was no difference between males
and females in the proportion being aware of the
condition. Among the 17 persons who reported
having diabetes, plasma glucose was 411mmol/l in
six persons (35.3%) and 57mmol/l in four (23.5%).
Only six persons reported they were attending a
clinic for diabetes. If persons with reported diabetes
are included in the group with probable diabetes,
the age-standardized prevalence was 0.6% (95%
CI 0.4–0.7).
There was strong evidence that participants with
plasma glucose 57mmol/l (probable hyperglycaemia
or diabetes) were older than those with normal
plasma glucose, in both males and females (Table 2).
There was no evidence of a difference in mean
BMI between males with probable hyperglycaemia/
diabetes and those with normal plasma glucose.
In contrast, there was strong evidence that mean
BMI was higher in females with probable hypergly-
caemia/diabetes than in those with normal plasma
glucose. In both males and females, there was
strong evidence that mean WC was higher in persons
with probable hyperglycaemia/diabetes than in
those with normal plasma glucose. In both sexes,
there was strong evidence that mean systolic and
diastolic blood pressure increased with increasing
glucose category.
Plasma glucose results were unavailable for 265
(9.7%) male and 427 (10.8%) female survey partici-
pants, because of either refusal to give a blood
sample or an insufficient sample. There was strong
evidence that participants with missing glucose results
were older than those with glucose results (mean
difference¼3.3 years, 95% CI 1.8–4.7, P<0.001), and
more likely to be HIV positive (19.1 vs 4.6%, P<0.001).
In addition, there was weak evidence that males with
missing glucose results had a higher mean WC than
males with glucose results (mean difference¼0.89cm,
95% CI –0.15 to 1.92, P¼0.09).
The proportions of males and females who reported
being a current regular smoker were 13.7% (95% CI
12.5–15.1) and 0.9% (95% CI 0.6–1.2), respectively,
Number of residents in study villages = approximately 20000
Number of residents censused in 2009 = 17268
Number of adults aged ≥ 13 = 10173 (58.9% of total residents
censused)
Number of adults who responded to survey questionnaire = 6678
(65.6% of those eligible)
Figure 1 Numbers of residents of study villages, adults
censused and survey participants
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smoking regularly.
Factors associated with plasma glucose
57mmol/l
Among males, factors associated with the prevalence
of probable hyperglycaemia/diabetes in the univariate
analysis included increasing age, current marriage,
level of education (prevalence highest among those
with less than primary education), current smoking,
WHR 50.95, increasing WHR, WC 594cm, and high
blood pressure (Table 3). In the multivariable ana-
lysis, increasing age was the only factor that remained
independently associated with the prevalence of prob-
able hyperglycaemia/diabetes. After adjusting for age,
there was no evidence of an independent association
with measures of obesity, BMI, WHR or WC, either
when included in the model as a categorical factor or
as a continuous measurement. However, after adjust-
ing for age, some evidence of an association between
the prevalence of probable hyperglycaemia/diabetes
and high blood pressure still remained.
Among females, factors associated with the preva-
lence of probable hyperglycaemia/diabetes in the
univariate analysis included increasing age, decreas-
ing education level, lower SES, increasing BMI,
WHR50.80, increasingWHR, WC 580cm and high
blood pressure. In the multivariable analysis, factors
independently associated with the prevalence of prob-
able hyperglycaemia/diabetes were increasing age,
decreasing education level and WC 580cm. There
was no evidence of an independent association with
other measures of adiposity, BMI or WHR, either
when included in the model as a categorical factor,
or as a continuous measurement. However, although
WC was the adiposity measure with the strongest as-
sociation with probable hyperglycaemia/diabetes,
there was some evidence of an association with
BMI, and with WHR, after adjusting for age and edu-
cation alone [adjusted odds ratio (OR)¼1.98, 95% CI
0.97–4.02, for BMI 525 vs BMI <18.5; adjusted
Table 1 Description of study participants
Males
(n¼2719)
Females
(n¼3959)
Socio-demographic/economic factors
Age (years)
<20 1037 (38.1%) 1123 (28.4%)
20–29 471 (17.3%) 838 (21.2%)
30–39 407 (15.0%) 700 (17.7%)
40–49 320 (11.8%) 530 (13.4%)
50–59 201 (7.4%) 347 (8.8%)
560 283 (10.4%) 421 (10.6%)
Mean (SD) age (years) 31.8 (18.4) 33.7 (17.6)
Currently married 1052 (38.7%) 1806 (45.6%)
Education level
Less than primary 167 (6.1%) 493 (12.5%)
Incomplete primary 1398 (51.5%) 1663 (42.0%)
Primary 501 (18.4%) 851 (21.5%)
Junior/secondary 556 (20.5%) 818 (20.7%)
Above secondary 95 (3.5%) 131 (3.3%)
Current regular smoker 373 (13.7%) 34 (0.9%)
Ever regular smoker 547 (20.2%) 50 (1.3%)
SES score tertile
a
Low 806 (30.1%) 993 (25.5%)
Middle 929 (34.7%) 1449 (37.3%)
High 939 (35.1%) 1448 (37.2%)
Clinical indicators
BMI (kg/m
2)
a
<18.5 768 (29.8%) 625 (16.5%)
18.5–24.9 1706 (66.2%) 2461 (65.0%)
25.0–29.9 92 (3.6%) 549 (14.5%)
530 13 (0.5%) 149 (3.9%)
Mean (SD) BMI (kg/m
2) 20.1 (2.9) 22.0 (4.0)
WHR 50.95 (males)/50.80
(females)
a
102 (3.8%) 2620 (71.3%)
Mean (SD) WHR 0.85 (0.05) 0.83 (0.06)
WC 594cm (males)/580cm
(females)
a
26 (1.0%) 1148 (31.2%)
Mean (SD) WC (cm) 72.6 (8.0) 76.0 (10.0)
Blood pressure 5140/90
a 602 (22.5%) 887 (22.6%)
Mean (SD) systolic
blood pressure
125.8 (18.0) 126.0 (19.0)
Mean (SD) diastolic
blood pressure
77.5 (11.7) 78.4 (10.9)
Reported hypertension 50 (1.8%) 216 (5.5%)
Random plasma glucose (mmol/l)
a
<7 2370 (96.6%) 3421 (96.9%)
7–11 74 (3.0%) 98 (2.8%)
411 10 (0.4%) 13 (0.4%)
(continued)
Table 1 Continued
Males
(n¼2719)
Females
(n¼3959)
Mean (SD) plasma
glucose
4.8 (1.6) 4.8 (1.3)
Reported diabetes 9 (0.3%) 10 (0.3%)
HIV serostatus
Positive 128 (4.8%) 269 (6.9%)
aMissing data for 51% of participants: SES index (45 males
and 69 females); BMI (140 males and 175 females); WHR
(43 males and 286 females); WC (41 males and 285 females);
blood pressure (43 males and 26 females); plasma glucose
results (265 males and 427 females).
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a
Normal
(glucose <7mmol/l)
b
Possible diabetes
(glucose 7–11mmol/l)
Probable diabetes
(glucose 411mmol/l)
n (col %) n (col %) n (col %)
Males
n 2370 74 10
Mean (SD) age (years) 31.1 (18.1) 43.8 (20.2) 56.6 (15.3)
Reported diabetes
No 2099 (88.6) 60 (81.1) 6 (60.0)
Yes 3 (0.1) 2 (2.7) 2 (20.0)
Don’t know 267 (11.3) 12 (16.2) 2 (20.0)
SES score tertile
Low 692 (29.7) 27 (37.0) 2 (20.0)
Middle 797 (34.2) 25 (34.2) 7 (70.0)
High 840 (36.1) 21 (28.8) 1 (10.0)
BMI (kg/m
2)
<18.5 683 (30.3) 18 (25.0) 3 (30.0)
18.5–24.9 1478 (65.7) 48 (66.7) 7 (70.0)
25.0–29.9 79 (3.5) 5 (6.9) 0 (–)
530 11 (0.5) 1 (1.4) 0 (–)
Mean (SD) BMI (kg/m
2) 20.1 (2.9) 20.3 (3.2) 20.7 (2.7)
WHR 50.95
No 2251 (96.4) 68 (91.9) 9 (90.0)
Yes 84 (3.6) 6 (8.1) 1 (10.0)
WHR tertile
Low 786 (33.7) 20 (27.0) 0 (–)
Middle 788 (33.7) 23 (30.1) 4 (40.0)
High 761 (32.6) 31 (41.9) 6 (60.0)
Mean (SD) WHR 0.85 (0.05) 0.86 (0.07) 0.90 (0.04)
WC 594cm
No 2318 (99.2) 71 (95.9) 10 (100)
Yes 18 (0.8) 3 (4.1) 0 (-)
Mean (SD) WC (cm) 72.5 (8.0) 75.5 (10.6) 80.8 (7.2)
Mean (SD) systolic blood pressure 125.4 (17.5) 135.2 (25.0) 148.1 (26.4)
Mean (SD) diastolic blood pressure 77.4 (11.5) 83.1 (18.1) 89.8 (13.8)
Females
n 3421 98 13
Mean (SD) age (years) 32.9 (17.4) 46.9 (17.9) 48.0 (14.1)
Reported diabetes
No 2949 (86.3) 72 (73.5) 4 (30.8)
Yes 4 (0.1) 2 (2.0) 4 (30.8)
Don’t know 466 (13.6) 24 (24.5) 5 (38.5)
SES score tertile
Low 836 (24.9) 30 (30.9) 5 (38.5)
Middle 1246 (37.1) 39 (40.2) 7 (53.8)
High 1280 (38.1) 28 (28.9) 1 (7.7)
(continued)
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after adjusting for age, education and WC 580cm,
some evidence of an association between the preva-
lence of probable hyperglycaemia/diabetes and high
blood pressure still remained.
Discussion
In this low-income rural community in southwest
Uganda, age-standardized prevalences of probable
diabetes and probable hyperglycaemia were 0.4 and
2.8%, respectively, and were similar in males and fe-
males. Less than 1% of males and 4% of females were
obese (BMI530kg/m
2), with 3.6% of males and
14.5% of females overweight (BMI 25–29.9kg/m
2).
The proportions of male and of female current regular
smokers were low (13.7 and 0.9%, respectively). The
commonest cardiovascular disease risk factor was
high blood pressure, found in  23% of both males
and females. The burden of chronic NCDs in this
relatively young rural population represents a chal-
lenge in providing an effective health-care response.
Our prevalence of probable diabetes (0.4%) is similar
to that reported in a largely rural population in The
Gambia (0.3%),
28 but much lower than that reported
in rural settings in Tanzania (1.1–1.7%),
29 Kenya
(2.2%)
30 and South Africa (3.9%).
31 Studies have gen-
erally found higher diabetes prevalence in urban than
rural settings, e.g. 8% in Kampala, Uganda,
32 and
6.4% in a combined group of urban and rural
Ghanaians.
33 Although sites may use different ways
of measuring and defining diabetes, such findings
highlight the heterogeneity of diabetes distribution
among communities in Africa
30 and the need for
comprehensive epidemiological mapping.
15 We found
a strong association between age and probable
hyperglycaemia/diabetes in both males and females,
consistent with other studies.
28–30 However, the asso-
ciation between obesity as measured by BMI and ele-
vated glucose was less clear, particularly among men.
Among women, after adjusting for age, abdominal
obesity was the strongest independent predictor of
Table 2 Continued
Normal
(glucose <7mmol/l)
b
Possible diabetes
(glucose 7–11mmol/l)
Probable diabetes
(glucose 411mmol/l)
n (col %) n (col %) n (col %)
BMI (kg/m
2)
<18.5 554 (16.9) 12 (13.0) 1 (10.0)
18.5–24.9 2128 (64.8) 55 (59.8) 3 (30.0)
25.0–29.9 467 (14.2) 19 (20.7) 4 (40.0)
530 134 (4.1) 6 (6.5) 2 (20.0)
Mean (SD) BMI (kg/m
2) 22.0 (4.0) 23.2 (4.8) 25.1 (6.1)
WHR 50.80
No 929 (29.3) 18 (19.6) 2 (15.4)
Yes 2245 (70.7) 74 (80.4) 11 (84.6)
WHR tertile
Low 1081 (34.1) 24 (26.1) 3 (23.1)
Middle 1057 (33.3) 25 (27.2) 5 (38.5)
High 1036 (32.6) 43 (46.7) 5 (38.5)
Mean (SD) WHR 0.83 (0.06) 0.85 (0.06) 0.85 (0.06)
WC 580cm
No 2220 (69.9) 45 (48.9) 3 (23.1)
Yes 955 (30.1) 47 (51.1) 10 (76.9)
Mean (SD) WC (cm) 75.7 (9.8) 82.1 (12.3) 87.2 (13.7)
Mean (SD) systolic blood pressure 125.7 (18.5) 134.8 (21.7) 139.2 (27.6)
Mean (SD) diastolic blood pressure 78.3 (10.7) 81.4 (11.5) 82.8 (12.9)
aCharacteristics of participants with normal glucose and those with glucose 57mmol/l were compared using
chi-square tests for categorical data and t-tests for continuous data. Comparisons are described in the text.
bRandom plasma glucose results interpreted as effectively post-prandial, therefore <7mmol/l is classified as ‘normal’,
7–11mmol/l indicates possible diabetes and 411mmol/l indicates probable diabetes.
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Males (n¼2454) Females (n¼3532)
Number with
glucose
57 (mmol/l)/total (%)
Unadjusted
OR
(95% CI)
Adjusted
OR
a
(95% CI)
Number with
glucose
57 (mmol/l)/total (%)
Unadjusted
OR
(95% CI)
Adjusted
OR
a
(95% CI)
Socio-demographic/economic factors
Age (years)
<20 12/950 (1.3) 1 1 7/1041 (0.7) 1 1
20–29 8/430 (1.9) 1.50 (0.60–3.75) 1.50 (0.60–3.75) 12/758 (1.6) 2.39 (0.93–6.17) 1.95 (0.72–5.28)
30–39 12/365 (3.3) 2.70 (1.18–6.19) 2.70 (1.18–6.19) 23/595 (3.9) 6.06 (2.55–14.38) 4.38 (1.78–10.77)
40–49 18/276 (6.5) 5.71 (2.62–12.43) 5.71 (2.62–14.43) 20/470 (4.3) 6.71 (2.78–16.19) 4.50 (1.81–11.22)
50–59 15/178 (8.4) 7.68 (3.35–17.64) 7.68 (3.35–17.64) 15/303 (5.0) 7.87 (3.13–19.83) 5.19 (1.98–13.63)
560 19/255 (7.5) 6.59 (3.04–14.28) 6.59 (3.04–14.28) 34/365 (9.3) 16.18 (6.80–38.52) 11.24 (4.44–28.44)
Currently married
Yes 47/934 (5.0) 1 1 53/1597 (3.3) 1 1
No 37/1519 (2.4) 0.46 (0.29–0.73) 0.97 (0.58–1.61) 58/1934 (3.0) 0.90 (0.61–1.32) 1.01 (0.66–1.55)
Education level
Secondary/above 17/578 (2.9) 1 1 10/849 (1.2) 1 1
Primary 21/456 (4.6) 1.60 (0.81–3.16) 1.73 (0.87–3.44) 24/770 (3.1) 2.71 (1.28–5.74) 2.69 (1.21–6.01)
Some primary 35/1270 (2.8) 0.92 (0.50–1.70) 0.97 (0.52–1.79) 53/1486 (3.6) 3.13 (1.57–6.22) 2.33 (1.10–4.94)
Less than primary 11/148 (7.4) 2.80 (1.21–6.47) 1.46 (0.62–3.45) 24/424 (5.7) 5.13 (2.39–10.99) 2.20 (0.93–5.18)
Current regular smoker
No 66/2124 (3.1) 1 1 110/3500 (3.1) 1 1
Yes 18/328 (5.5) 1.85 (1.05–3.25) 1.10 (0.61–1.97) 1/32 (3.1) 1.00 (0.13–7.64) 0.61 (0.07–4.97)
SES score tertile
Low 29/721 (4.0) 1 1 35/871 (4.0) 1 1
Middle 32/829 (3.9) 0.95 (0.55–1.63) 1.17 (0.68–2.04) 46/1292 (3.6) 0.88 (0.55–1.39) 0.93 (0.56–1.53)
High 22/862 (2.6) 0.62 (0.34–1.11) 0.81 (0.44–1.47) 29/1309 (2.2) 0.53 (0.32–0.89) 0.69 (0.38–1.24)
Clinical factors
BMI (kg/m
2)
<18.5 21/704 (3.0) 1 1 13/567 (2.3) 1 1
18.5–24.9 55/1533 (3.6) 1.21 (0.72–2.05) 1.03 (0.60–1.76) 58/2186 (2.7) 1.16 (0.63–2.16) 0.93 (0.47–1.83)
525 6/96 (6.3) 2.24 (0.84–5.96) 1.52 (0.56–4.12) 31/632 (4.9) 2.23 (1.14–4.38) 1.20 (0.51–2.82)
WHR 50.95 (males)/50.80 (females)
No 77/2328 (3.3) 1 1 20/949 (2.1) 1 1
Yes 7/91 (7.7) 2.48 (1.06–5.80) 1.57 (0.65–3.79) 85/2330 (3.6) 1.77 (1.07–2.91) 1.36 (0.79–2.34)
WHR tertile
Low 20/806 (2.5) 1 1 27/1108 (2.4) 1 1
Middle 27/815 (3.3) 1.36 (0.74–2.48) 1.22 (0.66–2.26) 30/1087 (2.8) 1.14 (0.67–1.94) 1.03 (0.58–1.81)
High 37/798 (4.6) 1.95 (1.10–3.47) 1.25 (0.68–2.29) 48/1084 (4.4) 1.88 (1.15–3.06) 1.20 (0.69–2.07)
WC 594cm (males)/580cm (females)
No 81/2399 (3.4) 1 1 48/2268 (2.1) 1 1
Yes 3/21 (14.3) 5.14 (1.30–20.31) 2.86 (0.71–11.46) 57/1012 (5.6) 2.83 (1.87–4.28) 2.04 (1.33–3.13)
Systolic BP 5140mmHg or diastolic BP 590mmHg
No 50/1872 (2.7) 1 1 63/2729 (2.3) 1 1
Yes 34/546 (6.2) 2.51 (1.56–4.04) 1.62 (0.98–2.70) 47/782 (6.0) 2.76 (1.84–4.13) 1.52 (0.97–2.39)
HIV serostatus
Negative 79/2351 (3.4) 1 1 105/3329 (3.2) 1 1
Positive 5/87 (5.7) 1.79 (0.67–4.77) 1.55 (0.58–4.16) 6/186 (3.2) 1.02 (0.43–2.38) 1.25 (0.52–3.01)
aAdjusted for all independent predictors in final multivariate model (i.e. for males, age category; for females, age category, education
and WC 580cm). ORs displayed for age group as a categorical factor, but included in final multivariate model as a linear term.
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not statistically significant) trend was seen in men.
Abdominal obesity, as indicated by a high WC, was
also found to be independently associated with dia-
betes in a study in Guinea.
34 The established BMI
cut-offs for overweight and obesity may not be good
indicators of cardiovascular disease risk in our study
population. A study in North America found that WC
was more sensitive than BMI in predicting cardiovas-
cular disease risk in different ethnic groups.
35
The observed prevalence of high blood pressure in
our study (22.5%) was lower than the prevalence of
hypertension reported in rural Rukungiri, Uganda
(30.5%),
36 but compatible with similar studies else-
where in Africa.
37 Overestimation of hypertension as
high blood pressure is likely due to the stress of
survey participation and the reliance on a single
measurement of blood pressure, which may be over-
estimated by as much as 50% compared with meas-
urements made on three visits.
38 However, we may
have underestimated prevalence of hypertension by
not including the few participants with reported
hypertension who had normal blood pressure. A sys-
tematic review of hypertension in Africa found that
prevalence varied extensively between and within stu-
dies, but was generally higher in urban than rural
settings, increased with age
37 and was as high as
that in most industrialized countries.
39 The low pro-
portion of current regular smokers in our study
(13.7% of males and 0.9% of females) reflects the
low national smoking prevalence among 15- to
49-year-olds in Uganda (18% in males and 0.9% in
females in 2006).
40
Obesity and overweight were more common among
females (4 and 14.5%, respectively) than males (0.5
and 3.6%, respectively). The combined prevalence
of obesity and overweight among females in our
study was similar to that nationally in Uganda (4.1
and 16.5%, respectively)
40 and compatible with that
found in rural settings elsewhere in Africa.
41
Although only 18.5% of women in our study had
BMI 525kg/m
2, the prevalence of abdominal obesity
as measured by WHR and WC was much higher (71.3
and 31.2%, respectively). Although the predictive value
of WC for diabetes and hypertension is well established
in some industrialized countries, e.g. the USA,
42 valid-
ation is necessary elsewhere. Rapidly increasing urban-
ization is associated with trends towards unhealthy
diets and sedentary lifestyles. The effects of changes
of globalization on lifestyle may be appearing slowly
in this rural community—the high prevalence of
under-nutrition (BMI<18.5kg/m
2) in males (29.8%)
and females (16.5%) reflects the low-income status
of the vast majority of the population. However
under-nutrition and obesity may exist side by side
within the same country, the same community and
even the same household.
3
Diagnosis of diabetes in an individual depends on at
least an initial and a confirmatory recommended
standard test,
43 based on measuring plasma glu-
cose fasting or 2h after an oral glucose load.
27 Since
either approach is of limited feasibility in a large
population-based survey in a rural setting in a
low-income country, we measured random plasma
glucose as a practical approach to estimating
population-level hyperglycaemia. Estimation of gly-
cated haemoglobin A1c as an alternative diagnostic
method is not currently recommended by the World
Health Organization (WHO) or the International
Diabetes Foundation because of insufficient validation
in people of different ages and ethnicity, inadequate
standardization of laboratory tests, and cost.
27 In
North America, random plasma glucose testing has
been shown to discriminate well between those with
and without diabetes, and with and without hyper-
glycaemia, when compared with the results of an oral
glucose tolerance test.
44 Furthermore, random plasma
glucose is a better discriminator for diabetes and
glucose intolerance than using age, BMI and race
45
and as good as using metabolic syndrome even
when it includes fasting glucose.
46 The performance
of random plasma glucose testing in rural Africa
cannot be assumed to be similar to that in North
America, and even if it does the positive predictive
values will be lower, reflecting lower prevalence in
rural Africa. However, it is reassuring that the
WHO-recommended cut-points
43 used in our study
were found in North America to be highly specific
(94 to 497%), although with much lower sensitivity
(<20%).
An additional limitation in plasma glucose testing
arises from the delay for practical reasons of up to
24h between taking the blood sample and measuring
the plasma glucose concentration. Whole blood for
glucose measurement was collected into sodium fluor-
ide tubes, which are designed to inhibit further glu-
cose metabolism in the sample. The sample was
separated, providing a stable plasma sample, within
half a day. However, it is known that prior to separ-
ation, even with sodium fluoride tubes, inhibition of
further glucose metabolism is not immediate, and
that over the first hour the glucose concentration con-
tinues to fall, becoming stable at  4h for the next
24–48h.
47 It is likely therefore that on average glucose
values were  0.5mmol/l lower than they would have
been had the measurement been made, or the sample
separated, immediately after collection.
47
Given the above factors the prevalence estimates re-
ported here, particularly for probable diabetes, are
likely to be an underestimation of the true prevalence.
It is likely that standard testing would confirm that
those classified by random plasma glucose as having
probable diabetes mostly do have diabetes, and as
having probable hyperglycaemia mostly do have dia-
betes, impaired glucose tolerance or impaired fasting
glycaemia. Given the dearth of population-based data
on hyperglycaemia in Africa, our data provide new
and important information.
168 INTERNATIONAL JOURNAL OF EPIDEMIOLOGYAlthough diabetes, hypertension and obesity are key
cardiovascular disease risk factors,
48 there have been
few large population-based studies of these conditions
in developing countries in Africa, and most have been
in urban settings.
49 Our study is unusual in providing
prevalence estimates of key cardiovascular disease risk
factors based on a large general population cohort in a
rural community in a low-income country in Africa.
A limitation of our study is incomplete (65.6%) par-
ticipation among all those identified as eligible in the
census. Males were less likely than females to take
part in the survey, probably because they are more
likely to be away from the household when the
survey team arrives. Maintaining a high participation
rate is a challenge in a long established community-
based annual HIV serosurvey. Some participants may
decline participation because they have previously had
a blood test for HIV, know their result and decide
against a repeat test. Although there was no evidence
of a difference in HIV serostatus between survey par-
ticipants and those who declined, survey participants
with missing glucose results (i.e. answered the ques-
tionnaire but declined a blood test) were more likely
to be HIV positive. Furthermore, participants with
missing plasma glucose results were older and had
a higher WC, and therefore are at higher risk of
diabetes, resulting in possible underestimation of dia-
betes prevalence. Lastly, we did not classify partici-
pants with reported diabetes who had normal
plasma glucose results in the group with probable
diabetes, which could lead to an underestimation of
diabetes prevalence.
Despite these limitations, our findings help to fill the
enormous gap between the sparse population-based
data available and the comprehensive data needed for
a good understanding of NCD distribution in Africa.
Such data on disease burden are crucial to aid planning
and implementation of NCD prevention and control
strategies. This study provides baseline findings of the
prevalence of diabetes, hypertension and obesity in a
rural community in a developing country in Africa at
a time of socio-economic development and globaliza-
tion, when these problems are increasing in cities and
likely to extend to rural areas. The chronic NCD burden
is also likely to increase further as more HIV-infected
people in Africa receive antiretroviral treatment (ART),
leadingtoreducedHIV-relatedmortalityandtopossible
metabolic side effects resulting from lifelong ART.
Responding to the global challenge of chronic NCDs
globally,includinginAfrica,requiressubstantialinvest-
ment
50 and concerted action through new alliances,
such as The Global Alliance for Chronic Diseases.
51
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KEY MESSAGES
  Existing research infrastructure for HIV surveys in Africa can provide a platform for assessing the
prevalence of other conditions, e.g. cardiovascular disease risk factors.
  The commonest cardiovascular disease risk factor was high blood pressure.
  Most people with probable diabetes or hyperglycaemia were not aware of it.
  Data on NCD burden are often limited in developing countries in Africa, but are crucial for planning
and implementation of prevention and control strategies.
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Data from successive World Heath Reports provide
convincing evidence that chronic non-communicable
diseases (NCDs) have become the leading cause of
premature deaths in low- and middle-income coun-
tries, except in sub-saharan Africa (SSA), which is
still struggling predominantly with HIV/AIDS.
1,2
However, information on NCDs from SSA is scarce
and most available reports are from urban areas. In
this issue of IJE, Maher and colleagues
3 report their
findings indicative of a detectable burden of high
blood glucose and a significant prevalence of high
blood pressure in a population-based HIV/AIDS
surveillance cohort in rural Uganda.
Prevalence estimates rely heavily on sampling strat-
egy and diagnostic criteria, including measurement
accuracy. The findings of Maher and colleagues are
based on the 20th annual follow-up data collected
from an HIV/AIDS surveillance cohort originally
established in 1989 in 25 villages in south-western
rural Uganda. Of the 20000 residents, all persons
aged513 years (n¼8760) were invited to participate
in the NCD survey, primarily focused on diabetes. A
total of 2719 (56.6%) males and 3959 (73.7%) females
consented to participate. A random plasma glucose
level411.0mmol/l was defined as ‘probable diabetes’,
and between 7.0 and 11.0mmol/l as ‘probable hyper-
glycemia’. Individuals with a single reading of systolic
BP of 140mmHg or diastolic BP of590mmHg in the
sitting positing measured with a digital (WelchAlleyn
OSZ 5) device were classified as having ‘probable high
blood pressure’.
The overall prevalence of probable diabetes in the
study participants was 0.4%, and 3% had probable
hyperglycaemia. About 10% of participants did not
provide blood samples for glucose determination.
The HIV sero-prevalence was significantly greater
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